Ask VialBase
other

Retinalamin

FDA: not-FDA-approved

Retinalamin is a retina bioregulator peptide used for retinal protection and visual acuity support. It helps stabilize or improve visual function in conditions like macular degeneration, diabetic retinopathy, and glaucoma. Bioregulator peptide targeting retinal tissue. Provides retinal protection and supports visual acuity. Operates epigenetically to maintain retinal cell health and gene expression. Helps stabilize or improve visual function by supporting retinal cell regeneration. - Retinal protection - Visual acuity support and improvement - Macular degeneration support - Diabetic retinopathy management - Glaucoma support - Standard: Administered via injection in clinical settings - Cycle: Short 10-20 day cycles per bioregulator protocol

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number —
Route —
What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
DURING CYCLE
  • None required (localized ocular effect)
POST-CYCLE
  • CMP
Safety & Regulatory Status
FDA STATUS not-FDA-approved

Regulatory status for Retinalamin may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.